OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -29.39M | -32.43M | -34.18M | -37.76M | -40.95M |
| Total Depreciation and Amortization | 935.40K | 1.22M | 1.07M | 1.04M | 1.01M |
| Total Amortization of Deferred Charges | 9.50K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.40M | 2.76M | 2.20M | 4.10M | 3.72M |
| Change in Net Operating Assets | 2.05M | 49.40K | -1.23M | -1.00M | -4.86M |
| Cash from Operations | -24.99M | -28.40M | -32.14M | -33.63M | -41.09M |
| Capital Expenditure | -16.00K | -244.90K | -244.90K | -289.80K | -549.50K |
| Sale of Property, Plant, and Equipment | 4.50K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -245.00K |
| Cash from Investing | -11.50K | -244.90K | -244.90K | -289.80K | -794.50K |
| Total Debt Issued | 2.00M | -- | -- | -- | -- |
| Total Debt Repaid | -1.15M | -1.24M | -1.33M | -1.23M | -1.03M |
| Issuance of Common Stock | 3.50M | 204.90K | 204.90K | 355.60K | 8.17M |
| Repurchase of Common Stock | -17.60K | -22.00K | -47.50K | -228.90K | -245.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -794.50K | -85.00K | 6.60K | 193.80K | -67.70K |
| Cash from Financing | 3.54M | -1.14M | -1.16M | -910.70K | 6.83M |
| Foreign Exchange rate Adjustments | -84.90K | -198.10K | -106.60K | -85.60K | -49.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.55M | -29.98M | -33.65M | -34.92M | -35.10M |